相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation
Roni Shouval et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Johan Torlen et al.
HAEMATOLOGICA (2016)
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Johan Torlen et al.
HAEMATOLOGICA (2016)
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice
Douglas E. Peterson et al.
CANCER MEDICINE (2016)
Mammalian Target of Rapamycin Inhibitor-Associated Stomatitis in Hematopoietic Stem Cell Transplantation Patients Receiving Sirolimus Prophylaxis for Graft-versus-Host Disease
Alessandro Villa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
A. Sureda et al.
BONE MARROW TRANSPLANTATION (2015)
Mucositis: pathobiology and management
Alessandro Villa et al.
CURRENT OPINION IN ONCOLOGY (2015)
Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)
Sharon Elad et al.
SUPPORTIVE CARE IN CANCER (2015)
Introduction to the Review Series on Advances in Hematopoietic Cell Transplantation
Robert S. Negrin
BLOOD (2014)
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Corey Cutler et al.
BLOOD (2014)
Graft-Versus-Host Disease Prophylaxis after Transplantation: A Network Meta-Analysis
Panayiotis D. Ziakas et al.
PLOS ONE (2014)
Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients
Karin Garming Legert et al.
SUPPORTIVE CARE IN CANCER (2014)
Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
Sepideh Shayani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
O. Ringden et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Mats Remberger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Transplantation in adult ALL
A. H. Goldstone et al.
Hematology-American Society of Hematology Education Program (2009)
Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients
Richard J. Knight et al.
CLINICAL TRANSPLANTATION (2007)
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation
Corey Cutler et al.
BLOOD (2007)
Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation
Ulrica Forslow et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2006)
Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate- and non-methotrexate-containing Graft-versus-host disease prophylaxis regimens
C Cutler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
C Cutler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study
C Troppmann et al.
TRANSPLANTATION (2003)
Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil.
T van Gelder et al.
TRANSPLANTATION (2003)
Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions
A Barasch et al.
ORAL ONCOLOGY (2003)
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation
ST Sonis et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
分享论文
